Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome.

Cheneau E, Pichard AD, Satler LF, Suddath WO, Weissman NJ, Waksman R.

Am J Cardiol. 2005 May 15;95(10):1240-2.

PMID:
15878001
2.

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M, Escaned J, Bañuelos C, Fernández-Ortiz A, Macaya C.

J Am Coll Cardiol. 2005 Mar 15;45(6):954-9.

3.
4.

Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance.

Agostoni P, Valgimigli M, Van Mieghem CA, Rodriguez-Granillo GA, Aoki J, Ong AT, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW.

Am J Cardiol. 2005 Mar 1;95(5):644-7.

PMID:
15721110
5.

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.

Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drzewiecki J, Banning A, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JM, Disco C, Koglin J, Russell ME, Colombo A; TAXUS II Study Group.

Circulation. 2005 Feb 22;111(7):900-5. Epub 2005 Feb 14.

6.

Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries.

Guédès A, Keller PF, L'Allier PL, Lespérance J, Grégoire J, Tardif JC.

J Am Coll Cardiol. 2005 Feb 15;45(4):559-64.

7.

Grading quality of evidence and strength of recommendations.

Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer T, Varonen H, Vist GE, Williams JW Jr, Zaza S; GRADE Working Group.

BMJ. 2004 Jun 19;328(7454):1490.

8.

Regional variations in cardiovascular mortality in Canada.

Filate WA, Johansen HL, Kennedy CC, Tu JV.

Can J Cardiol. 2003 Oct;19(11):1241-8.

PMID:
14571309
9.

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators.

N Engl J Med. 2003 Oct 2;349(14):1315-23.

10.

Continued improvement of clinical outcome and cost effectiveness following intravascular ultrasound guided PCI: insights from a prospective, randomised study.

Gaster AL, Slothuus Skjoldborg U, Larsen J, Korsholm L, von Birgelen C, Jensen S, Thayssen P, Pedersen KE, Haghfelt TH.

Heart. 2003 Sep;89(9):1043-9.

11.

Burden of cardiovascular disease in Canada.

Manuel DG, Leung M, Nguyen K, Tanuseputro P, Johansen H; Canadian Cardiovascular Outcomes Research Team.

Can J Cardiol. 2003 Aug;19(9):997-1004.

PMID:
12915926
12.

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.

Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; TAXUS II Study Group.

Circulation. 2003 Aug 19;108(7):788-94. Epub 2003 Aug 4.

13.
14.

TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.

Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, Staberock M, de Feyter P, Müller R, Regar E, Degertekin M, Ligthart JM, Disco C, Backx B, Russell ME.

Circulation. 2003 Feb 4;107(4):559-64.

15.

Cost-effectiveness of intracoronary ultrasound for percutaneous coronary interventions.

Mueller C, Hodgson JM, Schindler C, Perruchoud AP, Roskamm H, Buettner HJ.

Am J Cardiol. 2003 Jan 15;91(2):143-7.

PMID:
12521624
16.

Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study).

Oemrawsingh PV, Mintz GS, Schalij MJ, Zwinderman AH, Jukema JW, van der Wall EE; TULIP Study. Thrombocyte activity evaluation and effects of Ultrasound guidance in Long Intracoronary stent Placement.

Circulation. 2003 Jan 7;107(1):62-7.

17.

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.

Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME.

Circulation. 2003 Jan 7;107(1):38-42.

18.

Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.

Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, Centemero M, Maldonado G, Abizaid AS, Pinto I, Falotico R, Jaeger J, Popma JJ, Serruys PW.

Circulation. 2003 Jan 7;107(1):24-7.

19.

Medical costs of intravascular ultrasound optimization of stent deployment. Results of the multicenter randomized 'REStenosis after Intravascular ultrasound STenting' (RESIST) study.

Schiele F, Meneveau N, Seronde MF, Caulfield F, Pisa B, Arveux P, Bertrand B, Danchin N, Bassand JP.

Int J Cardiovasc Intervent. 2000 Dec;3(4):207-213.

PMID:
12431345
20.

Impact of intracoronary ultrasound guidance on long-term outcome of percutaneous coronary interventions in diabetics--insights from the randomized SIPS trial.

Mueller C, Mc Hodgson JB, Brutsche M, Perruchoud AP, Marsch S, Hunziker P, Buettner HJ.

Swiss Med Wkly. 2002 Jun 1;132(21-22):279-84.

PMID:
12362285

Supplemental Content

Support Center